NBS Principles - Spotting Trouble Early
Newborn Screening (NBS) is a public health program for early detection of serious, treatable conditions before symptoms appear.
Core tenets are based on the Wilson-Jungner criteria:
- The Condition: An important health problem with a recognizable latent or early symptomatic stage.
- The Test: A suitable, reliable, and acceptable screening test must be available.
- The System: An accepted treatment and facilities for diagnosis/treatment must be available. The cost should be economically balanced.
The US Recommended Uniform Screening Panel (RUSP) is a key global benchmark.

⭐ Ideal Sample Timing: Heel prick blood sample is best collected 24-72 hours after birth, ensuring adequate protein feeding.
Indian NBS - The National Picture
- Rashtriya Bal Swasthya Karyakram (RBSK): India's ambitious public health initiative for early identification and intervention in children.
- Core Strategy: The '4Ds' approach.
- Defects at birth
- Deficiencies
- Diseases
- Developmental delays including disability
- Screened Conditions (National Mandate):
- Congenital Hypothyroidism (CH)
- Congenital Adrenal Hyperplasia (CAH)
- G6PD Deficiency
- Phenylketonuria (PKU)
- Galactosemia
- Sickle Cell Disease
- Status: Not yet universal. Varies by state.
- Universal NBS: Kerala, Goa.
- Pilot Programs: Active in multiple other states.
⭐ RBSK targets comprehensive screening for over 27 crore children from birth to 18 years of age, a unique and wide-ranging age group for a national child health program.
The Usual Suspects - Disorders & Samples
- Sample Collection: Heel prick blood spot collected on a Guthrie card.
- Ideal Timing: 24-72 hours after birth. This timing is crucial to allow for clearance of maternal enzymes and for the infant to have sufficient protein intake, making metabolic disorders detectable.
| Disorder | Defective Enzyme/Protein | Key Clinical Finding (Untreated) | Test |
|---|---|---|---|
| Congenital Hypothyroidism | Thyroid hormone synthesis | Intellectual disability, coarse facies | TSH, T4 |
| Phenylketonuria (PKU) | Phenylalanine hydroxylase | Severe intellectual disability, seizures, musty odor | Tandem Mass Spectrometry (TMS) |
| Galactosemia | Galactose-1-phosphate uridyltransferase (GALT) | Cataracts, liver failure, E. coli sepsis | GALT activity, Beutler test |
| G6PD Deficiency | Glucose-6-Phosphate Dehydrogenase | Neonatal jaundice, acute hemolytic anemia | G6PD enzyme assay |
| Cystic Fibrosis | CFTR protein | Meconium ileus, recurrent lung infections | Immunoreactive trypsinogen (IRT) |
Lab & Follow-Up - Test, Trace, Treat
- Primary Technology: Tandem Mass Spectrometry (TMS) is the workhorse, measuring acylcarnitines and amino acids from a single dried blood spot.
- Hormonal Assays: Immunoassays are used for non-amino acid disorders, like measuring TSH for congenital hypothyroidism or 17-OHP for CAH.
⭐ Optimal sample collection time: 48-72 hours after birth. A sample taken before 24 hours is often invalid, especially for detecting Phenylketonuria (PKU), due to insufficient protein intake.
High-Yield Points - ⚡ Biggest Takeaways
- Newborn Screening (NBS) in India, under the RBSK program, is opportunistic, not yet universal.
- Congenital Hypothyroidism (CH) is the most common disorder detected, making it a top priority.
- Sample is collected via heel prick onto a filter paper card, ideally between 24-72 hours of life.
- Tandem Mass Spectrometry (TMS) is the core technology, enabling screening for multiple disorders from one blood spot.
- A positive screen is NOT diagnostic; it mandates a specific confirmatory test for diagnosis.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app